Literature DB >> 26707222

Serological statuses of pregnant women in an urban Brazilian population before and after the 2008 rubella immunization campaign.

Adriana Avila Moura1, Maria Júlia Gonçalves de Mello2, Jailson B Correia3.   

Abstract

BACKGROUND: Vaccinating populations against rubella aims to mitigate viral circulation and to ensure that women of childbearing age are immunized to reduce the incidence of congenital rubella syndrome. This study determined the serological statuses of pregnant women in an urban Brazilian population before and after the national rubella immunization campaign that was undertaken in 2008, and it assessed the socio-demographic factors associated with seronegativity.
METHODS: Pregnant women living in Maceió, Alagoas, Brazil, who participated in a municipal prenatal screening program that involved blood tests for rubella, were assessed between June 2007 and May 2012. Socio-demographic factors associated with seronegativity were assessed, including the year of the blood test, categorized as before or after the 2008 immunization campaign, and the women's birth cohorts, the women's ethnicities, the gestational ages at the first prenatal visit, and the women's districts of residence.
RESULTS: A total of 54,717 capillary blood samples were tested for rubella. The prevalence of pregnant women who were seronegative for rubella declined from 9.4% before the national immunization campaign to 2.8% after the national immunization campaign. Women were more likely to be seronegative for rubella before and after the immunization campaign if they were born between 1990 and 2000 or delayed starting prenatal care.
CONCLUSIONS: The decline in the prevalence of pregnant women who were seronegative for rubella to <5% indicates that the 2008 Brazilian rubella immunization campaign was successful in Maceió.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Congenital rubella syndrome; Immunization; Prenatal diagnosis; Rubella; Seroepidemiological studies

Mesh:

Substances:

Year:  2015        PMID: 26707222     DOI: 10.1016/j.vaccine.2015.12.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Sero-prevalence of rubella among pregnant women in Sub-Saharan Africa: a meta-analysis.

Authors:  Zemenu Yohannes Kassa; Siraj Hussen; Solomon Asnake
Journal:  Hum Vaccin Immunother       Date:  2020-03-20       Impact factor: 3.452

2.  The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region.

Authors:  Richard Luce; Balcha G Masresha; Regis Katsande; Amadou Fall; Messeret Eshetu Shibeshi
Journal:  J Immunol Sci       Date:  2018-07-28

3.  Seroepidemiology study of Cytomegalovirus and Rubella in pregnant women in Luanda, Angola: geospatial distribution and its association with socio-demographic and clinical-obstetric determinants.

Authors:  Amélia Vueba; Clarissa Faria; Ricardo Almendra; Paula Santana; Maria do Céu Sousa
Journal:  BMC Infect Dis       Date:  2022-02-05       Impact factor: 3.090

4.  Seroprevalence of HIV, HTLV, CMV, HBV and rubella virus infections in pregnant adolescents who received care in the city of Belém, Pará, Northern Brazil.

Authors:  Aubaneide Batista Guerra; Leonardo Quintão Siravenha; Rogério Valois Laurentino; Rosimar Neris Martins Feitosa; Vânia Nakauth Azevedo; Antonio Carlos Rosário Vallinoto; Ricardo Ishak; Luiz Fernando Almeida Machado
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-16       Impact factor: 3.007

5.  Recent trends in seroprevalence of rubella in Korean women of childbearing age: a cross-sectional study.

Authors:  Rihwa Choi; Yejin Oh; Youngju Oh; Sung Ho Kim; Sang Gon Lee; Eun Hee Lee
Journal:  BMJ Open       Date:  2020-01-02       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.